Inhibition of soluble epoxide hydrolase reverses bone loss in periodontitis by upregulating EMCN and inhibiting osteoclasts.

MLA

Li, Juanjuan, et al. “Inhibition of Soluble Epoxide Hydrolase Reverses Bone Loss in Periodontitis by Upregulating EMCN and Inhibiting Osteoclasts.” Stem Cell Research & Therapy, vol. 15, no. 1, Nov. 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s13287-024-04054-y.

APA

Li, J., Kou, N., Shi, X., Kong, L., Chen, W., Yang, X., Zhao, Y., Zhao, J., & Wang, F. (2024). Inhibition of soluble epoxide hydrolase reverses bone loss in periodontitis by upregulating EMCN and inhibiting osteoclasts. Stem Cell Research & Therapy, 15(1), 1–14. https://doi.org/10.1186/s13287-024-04054-y

Chicago

Li, Juanjuan, Ni Kou, Xiaoli Shi, Lingwenyao Kong, Weixian Chen, Xueping Yang, Yanrong Zhao, Jie Zhao, and Fu Wang. 2024. “Inhibition of Soluble Epoxide Hydrolase Reverses Bone Loss in Periodontitis by Upregulating EMCN and Inhibiting Osteoclasts.” Stem Cell Research & Therapy 15 (1): 1–14. doi:10.1186/s13287-024-04054-y.